Iconovo AB
Develops inhaled therapies and patented dry powder inhalers for global pharma partners.
ICO | ST
Overview
Corporate Details
- ISIN(s):
- SE0010868943 (+3 more)
- LEI:
- 549300CH7SEE52V2WD15
- Country:
- Sweden
- Address:
- Ideongatan 3B, 223 70 Lund
- Website:
- https://iconovo.se/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Iconovo AB is a pharmaceutical development company specializing in inhaled medicinal products. It partners with international pharmaceutical firms to develop both novel and generic drugs, offering an integrated service from concept to finalized product. Core capabilities include the development of proprietary, patented dry powder inhaler platforms and in-house powder formulation. By combining engineering expertise with pharmaceutical science, including analysis and advisory services, Iconovo functions as a comprehensive partner to accelerate the time-to-market for its clients' inhalation therapies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Iconovo AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Iconovo AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
